France amends its list of reimbursable medicines, including EZMEKLY

France has amended its official list of medicines that the state health insurance system reimburses. The change is set out in an annex that is not included in the excerpt, and it follows a December 2025 review of the drug EZMEKLY by the Haute Autorité de santé's transparency commission. The order was signed on 12 October 2026 and published on 30 October 2026.